Leadership Overview
PL Developments has 4 executives leading key functions including financial strategy, operational efficiency, human capital management, and logistics expansion.
Focused on delivering high-quality healthcare solutions, PL Developments maintains a commitment to manufacturing excellence and pharmaceutical innovation while driving sustainable growth across the competitive consumer healthcare market.
Focused on delivering high-quality healthcare solutions, PL Developments maintains a commitment to manufacturing excellence and pharmaceutical innovation while driving sustainable growth across the competitive consumer healthcare market.
Leadership Roles at PL Developments
Asaph Naaman - Chief Financial Officer
Asaph Naaman, the Chief Financial Officer at PL Developments, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with pharmaceutical industry regulations while managing complex budgetary requirements. This leadership role involves analyzing market trends to optimize investment in manufacturing infrastructure and distribution networks. By maintaining robust financial controls, Asaph Naaman directly impacts the long-term stability of the company. The Chief Financial Officer coordinates with the board to secure funding for new product development initiatives. Through precise fiscal oversight, Naaman supports the overarching mission of providing accessible healthcare products. This executive manages the financial risks associated with global supply chain fluctuations, ensuring the company remains competitive. Ultimately, Naaman secures the necessary resources to sustain high-volume production cycles and drive consistent revenue growth across all North American operations.
Mitchell Slade - Chief Operating Officer
Mitchell Slade, the Chief Operating Officer at PL Developments, manages the daily manufacturing and packaging workflows across all production facilities. Overseeing the operational output, the Chief Operating Officer ensures that every pharmaceutical product meets stringent quality standards and safety protocols. This leadership role involves streamlining production lines to maximize efficiency and reduce waste in the manufacturing process. By implementing advanced automation technologies, Mitchell Slade directly impacts the scalability of the company's healthcare product portfolio. The Chief Operating Officer collaborates with department heads to synchronize production schedules with market demand. Through continuous process improvement, Slade maintains high operational standards that define the company's reputation in the industry. This executive monitors performance metrics to identify bottlenecks in the manufacturing cycle. Ultimately, Slade drives operational excellence, ensuring that the company delivers reliable consumer healthcare solutions to a broad range of retail partners throughout the United States.
Claudia Neiva - Chief People Officer
Claudia Neiva, the Chief People Officer at PL Developments, directs all human capital strategies and organizational development initiatives. Overseeing the recruitment and retention of specialized talent, the Chief People Officer ensures that the workforce remains aligned with the company's mission of pharmaceutical excellence. This leadership role involves fostering a culture of safety, innovation, and professional growth within the manufacturing and distribution teams. By implementing comprehensive training programs, Claudia Neiva directly impacts the productivity and engagement levels of the entire staff. The Chief People Officer manages internal communications and performance management systems to support corporate objectives. Through strategic workforce planning, Neiva addresses the evolving needs of the healthcare manufacturing sector. This executive champions diversity and inclusion initiatives to strengthen the organizational foundation. Ultimately, Neiva cultivates a high-performing environment that empowers employees to contribute effectively to the company's success in the competitive consumer healthcare market.
Adam Singer - Chief Expansion and Logistics Officer
Adam Singer, the Chief Expansion and Logistics Officer at PL Developments, architects the strategy for supply chain optimization and regional market growth. Overseeing the distribution network, the Chief Expansion and Logistics Officer ensures the timely delivery of pharmaceutical and consumer healthcare products to diverse retail channels. This leadership role involves identifying new opportunities for facility expansion and enhancing the efficiency of logistics operations across North America. By integrating advanced tracking and inventory management systems, Adam Singer directly impacts the reliability of the company's distribution services. The Chief Expansion and Logistics Officer coordinates with external partners to streamline the movement of goods from manufacturing sites to end consumers. Through proactive logistics planning, Singer mitigates supply chain disruptions and maintains consistent product availability. This executive drives the expansion of the company's footprint to meet increasing market demand. Ultimately, Singer secures the logistical infrastructure necessary for sustained growth and operational success.
Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership AL
GM
CO
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership BP
AS
MP
AM
PAI Pharma is a privately held American pharmaceutical manufacturing company specializing in generic oral liquid medications, unit-dose pharmaceutical products, suspensions, syrups, injectable medicines, and patient-centric drug delivery solutions. Headquartered in Greenville, South Carolina, the organization operates as one of the leading manufacturers of liquid generic pharmaceuticals within the United States healthcare market. The company focuses heavily on producing high-quality oral liquid and unit-dose medications designed for hospitals, retail pharmacies, long-term care facilities, government healthcare systems, and institutional healthcare providers. The organization primarily generates revenue through the development, manufacturing, packaging, and distribution of prescription generic medicines and over-the-counter pharmaceutical products. Its product portfolio includes oral suspensions, oral solutions, elixirs, syrups, semi-solid medications, unit-dose pharmaceuticals, injectable medications, and specialty pharmaceutical formulations. PAI Pharma serves a wide customer base that includes retail pharmacy chains, independent pharmacies, acute care facilities, government agencies, institutional healthcare providers, and long-term care organizations throughout the United States.
Company Leadership KO
BR
ME
DC
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
NM
DO
Frequently Asked Questions Regarding PL Developments Top Executives and Leadership Team
